The global apheresis equipment market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8.8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Apheresis equipment is used to remove specific constituents from the blood, such as the cells, plasma, platelets or leukocytes, using either centrifugal or membrane filtration methods. The remaining blood components are then reintroduced into the bloodstream of the donor or patient. It finds application in blood banks and the treatment of various medical conditions. In recent years, the introduction of modern apheresis equipment has led to the development of advanced features, such as auto elutriation and fluid flow dynamics, and has enabled the collection of platelets or red blood cells (RBCs) concentrates.
Due to the spread of the coronavirus disease (COVID-19) and lack of an effective vaccine or treatment, convalescent plasma therapy is emerging as a measure for treating critically ill patients. Apheresis equipment is utilized in this therapy to collect convalescent plasma (CP) from fully recovered patients and transfuse it to active patients as a source of antibodies. Besides this, the growing prevalence of chronic diseases and neurological disorders, along with the rising number of blood donors, is also contributing to the market growth. Moreover, favorable reimbursement policies, coupled with improving healthcare infrastructure, are also driving the sales of apheresis equipment around the world. Other factors, such as the introduction of advanced variants with automated interface systems, screen navigation and graphical user interface displays, along with the increasing investments in research and development (R&D) activities, are expected to create a positive outlook for the market in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global apheresis equipment market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product, application, procedure, technology and end User.
Breakup by Product:
Breakup by Application:
Breakup by Procedure:
Breakup by Technology:
Breakup by End User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Asahi Kasei Corporation, B. Braun Melsungen Aktiengesellschaft, Baxter International Inc., Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA), Haemonetics Corporation, Hemacare Corporation (Charles River Laboratories Inc.), Kaneka Corporation, Kawasumi Laboratories Inc., Medica SpA, Nikkiso Co Ltd. and Terumo BCT Inc. (Terumo Corporation).
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Application, Procedure, Technology, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Asahi Kasei Corporation, B. Braun Melsungen Aktiengesellschaft, Baxter International Inc., Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA), Haemonetics Corporation, Hemacare Corporation (Charles River Laboratories Inc.), Kaneka Corporation, Kawasumi Laboratories Inc., Medica SpA, Nikkiso Co Ltd. and Terumo BCT Inc. (Terumo Corporation)|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at